to FR940405-1-00143 21 45 54 66 79 123 150 216 255 263 267 276 350 389 407 456 473 675 791 813 872 916
the FR940405-1-00143 72 46 51 57 87 91 103 118 124 134 170 178 185 212 219 227 230 256 264 286 301 326 355 361 365 370 396 408 430 434 460 463 466 474 482 485 529 551 555 571 579 583 591 598 603 606 621 629 637 645 655 659 663 668 682 686 707 717 730 744 786 799 804 807 837 862 891 897 903 906 910 917 926
skin FR940405-1-00143 9 47 125 292 351 414 427 472 480 918
, FR940405-1-00143 27 48 86 107 162 244 246 295 297 317 329 348 382 386 422 425 509 514 544 547 588 607 673 732 743 767 797 802
may FR940405-1-00143 2 49 825
cause FR940405-1-00143 1 50
ipd FR940405-1-00143 4 52 97 171 214
reaction FR940405-1-00143 1 53
occur FR940405-1-00143 2 55 826
. FR940405-1-00143 31 56 83 126 184 222 242 250 285 300 342 369 395 429 443 459 481 498 501 527 550 590 620 654 688 740 765 817 854 886 905 928
comment FR940405-1-00143 16 58 88 164 186 224 397 431 483 552 622 656 769 819 856 888 907
pointed FR940405-1-00143 2 59 746
out FR940405-1-00143 2 60 747
that FR940405-1-00143 25 61 90 128 166 188 204 226 321 399 433 554 624 628 658 662 692 698 748 760 771 821 832 858 890 909
a FR940405-1-00143 13 62 140 154 160 261 305 316 488 516 524 611 640 712
sunscreen FR940405-1-00143 4 63 362 581 713
's FR940405-1-00143 1 64
ability FR940405-1-00143 2 65 78
block FR940405-1-00143 1 67
visible FR940405-1-00143 1 68
light FR940405-1-00143 4 69 92 265 669
should FR940405-1-00143 1 70
not FR940405-1-00143 4 71 173 634 680
be FR940405-1-00143 5 72 157 193 208 852
confused FR940405-1-00143 1 73
or FR940405-1-00143 8 74 380 505 587 727 781 867 913
combined FR940405-1-00143 1 75
with FR940405-1-00143 12 76 159 211 260 291 315 330 439 449 542 615 827
its FR940405-1-00143 2 77 847
provide FR940405-1-00143 1 80
uva FR940405-1-00143 20 81 105 121 182 234 277 302 307 343 357 450 575 599 617 652 701 708 763 787 809
protection FR940405-1-00143 8 82 231 358 576 600 653 683 709
in FR940405-1-00143 10 84 102 111 233 373 419 520 644 650 741
addition FR940405-1-00143 2 85 742
argued FR940405-1-00143 2 89 165
sources FR940405-1-00143 2 93 670
used FR940405-1-00143 2 94 845
for FR940405-1-00143 11 95 117 139 147 175 412 705 720 798 839 861
both FR940405-1-00143 1 96
methods FR940405-1-00143 1 98
lack FR940405-1-00143 1 99
significant FR940405-1-00143 1 100
energy FR940405-1-00143 3 101 849 912
shorter FR940405-1-00143 1 104
wavelengths FR940405-1-00143 5 106 702 734 756 810
which FR940405-1-00143 3 108 114 896
are FR940405-1-00143 8 109 115 172 345 377 447 703 899
present FR940405-1-00143 2 110 385
sunlight FR940405-1-00143 1 112
and FR940405-1-00143 23 113 146 203 247 272 298 353 426 515 539 546 565 582 605 647 737 778 796 831 846 878 884 924
responsible FR940405-1-00143 1 116
preponderance FR940405-1-00143 1 119
of FR940405-1-00143 22 120 177 190 199 201 325 360 465 487 491 568 574 595 639 665 667 685 729 750 806 823 864
damage FR940405-1-00143 2 122 179
stating FR940405-1-00143 1 127
there FR940405-1-00143 1 129
is FR940405-1-00143 7 130 253 304 384 462 633 648
great FR940405-1-00143 2 131 142
demand FR940405-1-00143 1 132
among FR940405-1-00143 1 133
`` FR940405-1-00143 2 135 141
sunbather FR940405-1-00143 1 136
'' FR940405-1-00143 2 137 144
population FR940405-1-00143 1 138
looking FR940405-1-00143 1 143
tan FR940405-1-00143 3 145 155 221
an FR940405-1-00143 1 148
indicator FR940405-1-00143 1 149
predict FR940405-1-00143 1 151
how FR940405-1-00143 1 152
good FR940405-1-00143 1 153
can FR940405-1-00143 5 156 723 761 901 922
obtained FR940405-1-00143 2 158 774
product FR940405-1-00143 3 161 363 715
one FR940405-1-00143 4 163 223 818 887
tanning FR940405-1-00143 5 167 202 381 780 866
tests FR940405-1-00143 1 168
like FR940405-1-00143 1 169
appropriate FR940405-1-00143 1 174
measurement FR940405-1-00143 1 176
caused FR940405-1-00143 1 180
by FR940405-1-00143 6 181 195 578 602 636 711
radiation FR940405-1-00143 4 183 271 278 328
contended FR940405-1-00143 1 187
measures FR940405-1-00143 1 189
melanogenesis FR940405-1-00143 1 191
would FR940405-1-00143 3 192 206 851
misinterpreted FR940405-1-00143 1 194
consumers FR940405-1-00143 2 196 205
as FR940405-1-00143 3 197 417 783
indicators FR940405-1-00143 1 198
efficacy FR940405-1-00143 1 200
soon FR940405-1-00143 1 207
choosing FR940405-1-00143 1 209
products FR940405-1-00143 1 210
lowest FR940405-1-00143 1 213
rating FR940405-1-00143 1 215
help FR940405-1-00143 1 217
get FR940405-1-00143 1 218
deepest FR940405-1-00143 1 220
recommended FR940405-1-00143 1 225
agency FR940405-1-00143 1 228
adopt FR940405-1-00143 1 229
factor FR940405-1-00143 1 232
( FR940405-1-00143 11 235 240 279 309 338 416 496 610 671 789 811
pfa FR940405-1-00143 8 236 287 461 494 525 556 630 772
) FR940405-1-00143 11 237 249 284 313 340 421 500 619 678 794 816
test FR940405-1-00143 7 238 288 557 563 592 631 835
method FR940405-1-00143 5 239 252 376 558 632
refs FR940405-1-00143 1 241
24 FR940405-1-00143 2 243 390
25 FR940405-1-00143 2 245 499
26 FR940405-1-00143 1 248
this FR940405-1-00143 2 251 374
similar FR940405-1-00143 2 254 404
spf FR940405-1-00143 1 257
testing FR940405-1-00143 4 258 375 693 722
procedures FR940405-1-00143 2 259 694
modification FR940405-1-00143 1 262
source FR940405-1-00143 3 266 303 844
virtually FR940405-1-00143 1 268
eliminate FR940405-1-00143 1 269
uvb FR940405-1-00143 5 270 327 613 642 755
thus FR940405-1-00143 1 273
expose FR940405-1-00143 1 274
subjects FR940405-1-00143 2 275 290
greater FR940405-1-00143 1 280
than FR940405-1-00143 2 281 332
99 FR940405-1-00143 2 282 323
percent FR940405-1-00143 5 283 324 507 511 726
uses FR940405-1-00143 1 289
types FR940405-1-00143 1 293
i FR940405-1-00143 1 294
ii FR940405-1-00143 2 296 788
iii FR940405-1-00143 1 299
continuous FR940405-1-00143 1 306
spectrum FR940405-1-00143 1 308
preferably FR940405-1-00143 1 310
xenon FR940405-1-00143 1 311
arc FR940405-1-00143 1 312
filtered FR940405-1-00143 1 314
schott FR940405-1-00143 2 318 543
wg335 FR940405-1-00143 2 319 545
filter FR940405-1-00143 1 320
eliminates FR940405-1-00143 1 322
less FR940405-1-00143 1 331
1500 FR940405-1-00143 1 333
w FR940405-1-00143 1 334
per FR940405-1-00143 2 335 881
square FR940405-1-00143 1 336
meter FR940405-1-00143 1 337
w/m2 FR940405-1-00143 2 339 677
irradiance FR940405-1-00143 2 341 666
exposures FR940405-1-00143 3 344 830 921
delivered FR940405-1-00143 2 346 915
at FR940405-1-00143 3 347 874 895
increments FR940405-1-00143 1 349
above FR940405-1-00143 1 352
below FR940405-1-00143 3 354 757 885
expected FR940405-1-00143 1 356
level FR940405-1-00143 2 359 664
times FR940405-1-00143 1 364
minimal FR940405-1-00143 4 366 444 467 475
response FR940405-1-00143 5 367 441 445 468 476
dose FR940405-1-00143 4 368 469 477 859
endpoints FR940405-1-00143 3 371 784 863
measured FR940405-1-00143 1 372
delayed FR940405-1-00143 3 378 779 865
erythema FR940405-1-00143 3 379 782 868
whichever FR940405-1-00143 1 383
observed FR940405-1-00143 1 387
16 FR940405-1-00143 1 388
hours FR940405-1-00143 1 391
after FR940405-1-00143 2 392 893
uv FR940405-1-00143 3 393 534 843
exposure FR940405-1-00143 3 394 451 894
stated FR940405-1-00143 7 398 553 623 691 770 820 857
these FR940405-1-00143 4 400 625 751 920
acute FR940405-1-00143 1 401
responses FR940405-1-00143 2 402 898
have FR940405-1-00143 1 403
action FR940405-1-00143 2 405 410
spectra FR940405-1-00143 2 406 411
chronic FR940405-1-00143 1 409
nonmelanoma FR940405-1-00143 1 413
cancer FR940405-1-00143 1 415
determined FR940405-1-00143 1 418
animals FR940405-1-00143 1 420
solar FR940405-1-00143 2 423 530
elastosis FR940405-1-00143 1 424
wrinkling FR940405-1-00143 1 428
added FR940405-1-00143 3 432 657 908
data FR940405-1-00143 2 435 660
indicate FR940405-1-00143 2 436 627
equivalent FR940405-1-00143 1 437
results FR940405-1-00143 6 438 486 561 626 904 927
either FR940405-1-00143 1 440
parameter FR940405-1-00143 1 442
doses FR940405-1-00143 1 446
elicited FR940405-1-00143 1 448
ranging FR940405-1-00143 1 452
from FR940405-1-00143 1 453
approximately FR940405-1-00143 1 454
80 FR940405-1-00143 1 455
250 FR940405-1-00143 1 457
j/cm2 FR940405-1-00143 1 458
ratio FR940405-1-00143 1 464
on FR940405-1-00143 2 470 478
protected FR940405-1-00143 1 471
unprotected FR940405-1-00143 1 479
submitted FR940405-1-00143 1 484
multicenter FR940405-1-00143 1 489
evaluation FR940405-1-00143 1 490
sunscreens FR940405-1-00143 4 492 502 584 687
using FR940405-1-00143 4 493 523 695 775
methodology FR940405-1-00143 1 495
ref FR940405-1-00143 1 497
containing FR940405-1-00143 2 503 585
2 FR940405-1-00143 2 504 883
5 FR940405-1-00143 1 506
oxybenzone FR940405-1-00143 2 508 589
7 FR940405-1-00143 1 510
padimate FR940405-1-00143 2 512 608
o FR940405-1-00143 2 513 609
placebo FR940405-1-00143 3 517 580 604
were FR940405-1-00143 2 518 540
tested FR940405-1-00143 1 519
five FR940405-1-00143 1 521
laboratories FR940405-1-00143 1 522
protocol FR940405-1-00143 1 526
all FR940405-1-00143 1 528
simulators FR940405-1-00143 1 531
had FR940405-1-00143 1 532
intrinsic FR940405-1-00143 1 533
reflecting/ir FR940405-1-00143 1 535
absorbing FR940405-1-00143 1 536
dichroic FR940405-1-00143 1 537
mirrors FR940405-1-00143 1 538
fitted FR940405-1-00143 1 541
ug11 FR940405-1-00143 1 548
filters FR940405-1-00143 2 549 718
yielded FR940405-1-00143 1 559
reproducible FR940405-1-00143 1 560
between FR940405-1-00143 5 562 570 597 735 876
centers FR940405-1-00143 1 564
was FR940405-1-00143 2 566 593
capable FR940405-1-00143 1 567
distinguishing FR940405-1-00143 2 569 596
three FR940405-1-00143 1 572
levels FR940405-1-00143 1 573
provided FR940405-1-00143 2 577 601
2- FR940405-1-00143 1 586
incapable FR940405-1-00143 1 594
strong FR940405-1-00143 2 612 641
absorber FR940405-1-00143 1 614
little FR940405-1-00143 1 616
absorbency FR940405-1-00143 1 618
influenced FR940405-1-00143 1 635
presence FR940405-1-00143 1 638
blocker FR940405-1-00143 1 643
formulation FR940405-1-00143 1 646
specific FR940405-1-00143 1 649
identifying FR940405-1-00143 1 651
show FR940405-1-00143 1 661
ie FR940405-1-00143 1 672
300 FR940405-1-00143 1 674
1200 FR940405-1-00143 1 676
did FR940405-1-00143 1 679
influence FR940405-1-00143 1 681
factors FR940405-1-00143 1 684
two FR940405-1-00143 1 689
comments FR940405-1-00143 2 690 745
modified FR940405-1-00143 3 696 752 776
lamps FR940405-1-00143 3 697 753 777
produce FR940405-1-00143 1 699
mostly FR940405-1-00143 1 700
unsatisfactory FR940405-1-00143 1 704
evaluating FR940405-1-00143 1 706
afforded FR940405-1-00143 1 710
drug FR940405-1-00143 1 714
because FR940405-1-00143 1 716
required FR940405-1-00143 1 719
such FR940405-1-00143 1 721
remove FR940405-1-00143 1 724
40 FR940405-1-00143 1 725
more FR940405-1-00143 1 728
critical FR940405-1-00143 1 731
damaging FR940405-1-00143 1 733
320 FR940405-1-00143 3 736 758 790
340 FR940405-1-00143 2 738 792
nm FR940405-1-00143 4 739 759 793 815
some FR940405-1-00143 1 749
contain FR940405-1-00143 1 754
overwhelm FR940405-1-00143 1 762
effects FR940405-1-00143 1 764
however FR940405-1-00143 1 766
another FR940405-1-00143 2 768 855
values FR940405-1-00143 1 773
weigh FR940405-1-00143 1 785
heavily FR940405-1-00143 1 795
most FR940405-1-00143 1 800
part FR940405-1-00143 1 801
ignore FR940405-1-00143 1 803
contribution FR940405-1-00143 1 805
longer FR940405-1-00143 1 808
360 FR940405-1-00143 1 812
400 FR940405-1-00143 1 814
failure FR940405-1-00143 1 822
reciprocity FR940405-1-00143 2 824 860
very FR940405-1-00143 1 828
long FR940405-1-00143 1 829
making FR940405-1-00143 1 833
each FR940405-1-00143 2 834 840
exactly FR940405-1-00143 1 836
same FR940405-1-00143 1 838
differently FR940405-1-00143 1 841
configured FR940405-1-00143 1 842
particular FR940405-1-00143 1 848
distribution FR940405-1-00143 1 850
impossible FR940405-1-00143 1 853
has FR940405-1-00143 1 869
been FR940405-1-00143 1 870
reported FR940405-1-00143 1 871
fail FR940405-1-00143 1 873
irradiances FR940405-1-00143 1 875
10 FR940405-1-00143 1 877
50 FR940405-1-00143 1 879
milliwatts FR940405-1-00143 1 880
cm FR940405-1-00143 1 882
noted FR940405-1-00143 1 889
interval FR940405-1-00143 1 892
evaluated FR940405-1-00143 1 900
bias FR940405-1-00143 1 902
infrared FR940405-1-00143 1 911
heat FR940405-1-00143 1 914
during FR940405-1-00143 1 919
affect FR940405-1-00143 1 923
alter FR940405-1-00143 1 925
the FR940405-1-00144 52 0 12 25 68 80 89 92 96 102 155 158 177 187 191 195 208 215 218 233 236 251 256 260 268 272 283 288 309 315 338 347 376 384 388 397 409 415 420 426 435 441 453 465 473 483 500 520 524 530 544 549 557
comment FR940405-1-00144 7 1 81 149 289 310 339 377
stated FR940405-1-00144 2 2 290
that FR940405-1-00144 7 3 153 291 312 341 379 523
no FR940405-1-00144 1 4
currently FR940405-1-00144 1 5
existing FR940405-1-00144 1 6
lamps FR940405-1-00144 5 7 21 49 84 110
accurately FR940405-1-00144 3 8 66 143
and FR940405-1-00144 12 9 63 98 124 182 263 274 303 329 349 417 425
fully FR940405-1-00144 1 10
reproduce FR940405-1-00144 1 11
uva FR940405-1-00144 13 13 19 38 58 76 103 140 145 454 478 484 515 534
spectrum FR940405-1-00144 3 14 97 270
of FR940405-1-00144 26 15 73 88 95 105 157 179 194 214 217 229 235 255 259 271 277 301 324 364 387 391 400 419 440 475 533
sunlight FR940405-1-00144 3 16 75 403
. FR940405-1-00144 20 17 46 77 107 131 147 170 173 186 202 227 253 287 308 334 354 375 408 546 570
pure FR940405-1-00144 1 18
i FR940405-1-00144 1 20
, FR940405-1-00144 21 22 24 28 82 115 211 292 299 313 322 326 328 337 345 357 367 396 561 563 566 568
eg FR940405-1-00144 2 23 562
uvasun FR940405-1-00144 1 26
series FR940405-1-00144 1 27
are FR940405-1-00144 5 29 55 205 306 472
used FR940405-1-00144 1 30
primarily FR940405-1-00144 1 31
for FR940405-1-00144 5 32 282 383 551 556
photochemotherapy FR940405-1-00144 1 33
where FR940405-1-00144 1 34
only FR940405-1-00144 1 35
longer FR940405-1-00144 1 36
wave FR940405-1-00144 1 37
( FR940405-1-00144 3 39 168 352
above FR940405-1-00144 2 40 447
340 FR940405-1-00144 1 41
nm FR940405-1-00144 3 42 62 123
) FR940405-1-00144 3 43 172 356
is FR940405-1-00144 2 44 317
wanted FR940405-1-00144 1 45
xenon FR940405-1-00144 2 47 108
arc FR940405-1-00144 2 48 109
modified FR940405-1-00144 1 50
with FR940405-1-00144 3 51 112 370
a FR940405-1-00144 9 52 151 166 230 362 392 458 490 506
wg345 FR940405-1-00144 1 53
filter FR940405-1-00144 1 54
deficient FR940405-1-00144 1 56
in FR940405-1-00144 7 57 100 223 335 402 442 476
energy FR940405-1-00144 3 59 90 141
below FR940405-1-00144 2 60 121
335 FR940405-1-00144 1 61
do FR940405-1-00144 2 64 519
not FR940405-1-00144 4 65 359 467 528
reflect FR940405-1-00144 1 67
energies FR940405-1-00144 1 69
or FR940405-1-00144 2 70 114
damage FR940405-1-00144 1 71
risk FR940405-1-00144 2 72 146
natural FR940405-1-00144 1 74
according FR940405-1-00144 1 78
to FR940405-1-00144 6 79 142 413 451 482 487
such FR940405-1-00144 1 83
remove FR940405-1-00144 1 85
too FR940405-1-00144 2 86 137
much FR940405-1-00144 2 87 138
at FR940405-1-00144 2 91 434
short FR940405-1-00144 1 93
end FR940405-1-00144 1 94
result FR940405-1-00144 1 99
overestimating FR940405-1-00144 1 101
effectiveness FR940405-1-00144 1 104
sunscreens FR940405-1-00144 1 106
filtered FR940405-1-00144 1 111
1- FR940405-1-00144 1 113
wg335 FR940405-1-00144 2 116 133
filters FR940405-1-00144 2 117 134
contain FR940405-1-00144 1 118
uvb FR940405-1-00144 1 119
wavelengths FR940405-1-00144 1 120
320 FR940405-1-00144 1 122
thus FR940405-1-00144 2 125 395
can FR940405-1-00144 2 126 331
greatly FR940405-1-00144 1 127
affect FR940405-1-00144 1 128
test FR940405-1-00144 5 129 432 444 502 526
results FR940405-1-00144 2 130 474
thicker FR940405-1-00144 1 132
cut FR940405-1-00144 1 135
off FR940405-1-00144 1 136
lower FR940405-1-00144 1 139
represent FR940405-1-00144 1 144
one FR940405-1-00144 1 148
submitted FR940405-1-00144 1 150
method FR940405-1-00144 7 152 175 188 295 351 503 560
assesses FR940405-1-00144 1 154
attenuation FR940405-1-00144 1 156
incident FR940405-1-00144 1 159
solar FR940405-1-00144 3 160 245 279
radiation FR940405-1-00144 4 161 246 516 535
on FR940405-1-00144 3 162 207 319
human FR940405-1-00144 2 163 320
skin FR940405-1-00144 8 164 196 219 237 252 261 321 373
by FR940405-1-00144 5 165 238 457 489 537
sunscreen FR940405-1-00144 8 167 231 265 393 459 491 507 539
ref FR940405-1-00144 2 169 353
27 FR940405-1-00144 1 171
this FR940405-1-00144 4 174 294 342 380
utilizes FR940405-1-00144 1 176
principles FR940405-1-00144 1 178
diffuse FR940405-1-00144 1 180
reflectance FR940405-1-00144 1 181
fluorescence FR940405-1-00144 1 183
excitation FR940405-1-00144 1 184
spectroscopy FR940405-1-00144 1 185
directly FR940405-1-00144 1 189
measures FR940405-1-00144 1 190
optical FR940405-1-00144 1 192
properties FR940405-1-00144 3 193 226 258
decoupled FR940405-1-00144 1 197
from FR940405-1-00144 2 198 361
its FR940405-1-00144 2 199 224
biological FR940405-1-00144 1 200
responses FR940405-1-00144 1 201
both FR940405-1-00144 1 203
procedures FR940405-1-00144 2 204 424
based FR940405-1-00144 1 206
same FR940405-1-00144 1 209
principle FR940405-1-00144 1 210
any FR940405-1-00144 1 212
modification FR940405-1-00144 1 213
surface FR940405-1-00144 2 216 234
will FR940405-1-00144 2 220 404
produce FR940405-1-00144 1 221
changes FR940405-1-00144 1 222
absorption FR940405-1-00144 2 225 257
application FR940405-1-00144 2 228 266
modifies FR940405-1-00144 1 232
providing FR940405-1-00144 1 239
an FR940405-1-00144 2 240 552
additional FR940405-1-00144 1 241
barrier FR940405-1-00144 1 242
through FR940405-1-00144 1 243
which FR940405-1-00144 2 244 439
must FR940405-1-00144 1 247
penetrate FR940405-1-00144 1 248
before FR940405-1-00144 2 249 262
reaching FR940405-1-00144 1 250
measurement FR940405-1-00144 1 254
after FR940405-1-00144 1 264
yields FR940405-1-00144 1 267
transmission FR940405-1-00144 1 269
product FR940405-1-00144 4 273 461 493 509
permits FR940405-1-00144 1 275
calculation FR940405-1-00144 1 276
it FR940405-1-00144 1 278
protection FR940405-1-00144 5 280 398 455 485 512
value FR940405-1-00144 1 281
wavelength FR940405-1-00144 1 284
range FR940405-1-00144 1 285
investigated FR940405-1-00144 1 286
because FR940405-1-00144 2 293 314
allows FR940405-1-00144 2 296 382
repetitive FR940405-1-00144 1 297
testing FR940405-1-00144 6 298 316 343 423 479 559
evaluations FR940405-1-00144 1 300
substantivity FR940405-1-00144 1 302
water FR940405-1-00144 1 304
resistance FR940405-1-00144 1 305
possible FR940405-1-00144 1 307
contended FR940405-1-00144 1 311
done FR940405-1-00144 1 318
questions FR940405-1-00144 2 323 429
binding FR940405-1-00144 1 325
distribution FR940405-1-00144 2 327 565
photodegradation FR940405-1-00144 1 330
be FR940405-1-00144 4 332 405 449 468
answered FR940405-1-00144 1 333
addition FR940405-1-00144 1 336
maintained FR940405-1-00144 1 340
procedure FR940405-1-00144 2 344 381
like FR940405-1-00144 2 346 412
diffey FR940405-1-00144 1 348
robson FR940405-1-00144 1 350
12 FR940405-1-00144 1 355
does FR940405-1-00144 3 358 499 527
suffer FR940405-1-00144 1 360
lack FR940405-1-00144 1 363
dose FR940405-1-00144 1 365
reciprocity FR940405-1-00144 1 366
as FR940405-1-00144 1 368
observed FR940405-1-00144 1 369
uvainduced FR940405-1-00144 1 371
acute FR940405-1-00144 1 372
reactions FR940405-1-00144 1 374
concluded FR940405-1-00144 1 378
correct FR940405-1-00144 1 385
estimation FR940405-1-00144 1 386
attenuating FR940405-1-00144 1 389
power FR940405-1-00144 1 390
; FR940405-1-00144 1 394
potential FR940405-1-00144 1 399
products FR940405-1-00144 2 401 541
correctly FR940405-1-00144 1 406
estimated FR940405-1-00144 1 407
agency FR940405-1-00144 1 410
would FR940405-1-00144 3 411 448 464
discuss FR940405-1-00144 1 414
advantages FR940405-1-00144 1 416
disadvantages FR940405-1-00144 1 418
various FR940405-1-00144 1 421
recommended FR940405-1-00144 1 422
following FR940405-1-00144 1 427
specific FR940405-1-00144 1 428
regarding FR940405-1-00144 1 430
these FR940405-1-00144 1 431
methods FR940405-1-00144 3 433 445 480
meeting FR940405-1-00144 1 436
: FR940405-1-00144 1 437
1. FR940405-1-00144 1 438
vitro FR940405-1-00144 2 443 477
described FR940405-1-00144 1 446
adequate FR940405-1-00144 1 450
evaluate FR940405-1-00144 1 452
provided FR940405-1-00144 2 456 486
drug FR940405-1-00144 4 460 492 508 540
? FR940405-1-00144 5 462 470 497 517 542
why FR940405-1-00144 1 463
others FR940405-1-00144 1 466
appropriate FR940405-1-00144 2 469 553
2. FR940405-1-00144 1 471
relevant FR940405-1-00144 1 481
consumers FR940405-1-00144 1 488
during FR940405-1-00144 1 494
normal FR940405-1-00144 1 495
use FR940405-1-00144 1 496
3. FR940405-1-00144 1 498
app FR940405-1-00144 2 501 525
demonstrate FR940405-1-00144 1 504
whether FR940405-1-00144 1 505
provides FR940405-1-00144 1 510
meaningful FR940405-1-00144 1 511
against FR940405-1-00144 1 513
harmful FR940405-1-00144 1 514
4. FR940405-1-00144 1 518
data FR940405-1-00144 2 521 545
show FR940405-1-00144 1 522
overestimate FR940405-1-00144 1 529
actual FR940405-1-00144 1 531
amount FR940405-1-00144 1 532
blocked FR940405-1-00144 1 536
most FR940405-1-00144 1 538
identify FR940405-1-00144 1 543
5. FR940405-1-00144 1 547
describe FR940405-1-00144 1 548
specifications FR940405-1-00144 1 550
light FR940405-1-00144 1 554
source FR940405-1-00144 1 555
ipd FR940405-1-00144 1 558
spectral FR940405-1-00144 1 564
intensity FR940405-1-00144 1 567
etc FR940405-1-00144 1 569
6. FR940405-1-00145 1 0
what FR940405-1-00145 1 1
uva FR940405-1-00145 8 2 29 44 104 219 261 265 337
radiation FR940405-1-00145 2 3 725
doses FR940405-1-00145 1 4
are FR940405-1-00145 6 5 90 138 352 367 531
appropriate FR940405-1-00145 2 6 169
for FR940405-1-00145 7 7 167 172 221 523 592 761
use FR940405-1-00145 1 8
in FR940405-1-00145 16 9 201 287 343 376 378 405 434 436 474 476 691 726 765 885 888
the FR940405-1-00145 58 10 17 34 41 49 54 66 71 76 84 93 101 108 113 117 125 130 141 146 153 160 165 173 187 202 212 227 243 246 256 275 288 301 318 332 372 379 410 425 437 452 470 477 485 503 513 517 524 547 551 569 580 589 593 606 613 629 733
ipd FR940405-1-00145 5 11 18 35 55 77
test FR940405-1-00145 3 12 56 119
? FR940405-1-00145 9 13 31 46 64 88 106 123 143 162
7. FR940405-1-00145 1 14
when FR940405-1-00145 1 15
should FR940405-1-00145 6 16 294 412 422 466 483
response FR940405-1-00145 2 19 79
be FR940405-1-00145 8 20 200 250 290 295 354 369 467
read_immediately FR940405-1-00145 1 21
, FR940405-1-00145 77 22 59 61 177 179 182 184 191 196 235 237 242 274 310 314 315 326 356 449 450 490 492 495 498 501 510 515 555 573 620 621 641 643 648 651 653 657 660 664 669 674 678 681 683 685 688 690 696 705 710 729 738 740 747 750 755 768 772 774 784 789 799 804 809 819 824 829 839 844 849 861 866 875 880 894 899 901
or FR940405-1-00145 8 23 25 148 281 307 312 402 447
1 FR940405-1-00145 2 24 634
2 FR940405-1-00145 3 26 702 838
hours FR940405-1-00145 1 27
after FR940405-1-00145 3 28 132 567
exposure FR940405-1-00145 3 30 133 158
8. FR940405-1-00145 1 32
is FR940405-1-00145 4 33 57 386 599
reaction FR940405-1-00145 1 36
relevant FR940405-1-00145 4 37 97 299 330
to FR940405-1-00145 20 38 98 152 205 210 252 300 317 331 353 368 389 396 451 506 533 585 602 622 644
protection FR940405-1-00145 4 39 99 262 338
of FR940405-1-00145 21 40 92 100 349 381 444 463 479 502 512 520 553 571 579 608 667 717 732 736 884 891
skin FR940405-1-00145 4 42 102 154 767
from FR940405-1-00145 4 43 103 268 637
damage FR940405-1-00145 2 45 105
9. FR940405-1-00145 1 47
do FR940405-1-00145 3 48 70 112
available FR940405-1-00145 3 50 72 549
data FR940405-1-00145 8 51 67 73 114 126 293 329 391
demonstrate FR940405-1-00145 2 52 74
that FR940405-1-00145 6 53 75 116 197 278 358
stable FR940405-1-00145 1 58
nonvariable FR940405-1-00145 1 60
and FR940405-1-00145 21 62 215 238 264 298 328 334 339 392 427 482 516 537 550 582 670 686 713 751 887 897
reproducible FR940405-1-00145 1 63
identify FR940405-1-00145 3 65 107 124
. FR940405-1-00145 42 68 110 127 186 226 255 272 292 304 346 364 384 399 420 431 460 526 544 566 588 612 631 694 700 742 776 782 787 793 802 807 813 822 827 833 842 847 853 859 864 870 903
10. FR940405-1-00145 1 69
testing FR940405-1-00145 9 78 95 157 175 220 266 340 716 890
obeys FR940405-1-00145 2 80 120
dose FR940405-1-00145 2 81 121
reciprocity FR940405-1-00145 2 82 122
over FR940405-1-00145 1 83
anticipated FR940405-1-00145 1 85
irradiance FR940405-1-00145 1 86
range FR940405-1-00145 1 87
11. FR940405-1-00145 1 89
results FR940405-1-00145 4 91 109 142 161
pfa FR940405-1-00145 5 94 118 136 156 174
procedure FR940405-1-00145 1 96
12. FR940405-1-00145 1 111
show FR940405-1-00145 1 115
13. FR940405-1-00145 1 128
can FR940405-1-00145 1 129
interval FR940405-1-00145 1 131
at FR940405-1-00145 4 134 245 409 628
which FR940405-1-00145 1 135
responses FR940405-1-00145 1 137
read FR940405-1-00145 1 139
affect FR940405-1-00145 2 140 159
14. FR940405-1-00145 1 144
does FR940405-1-00145 1 145
heat FR940405-1-00145 1 147
infrared FR940405-1-00145 1 149
energy FR940405-1-00145 1 150
delivered FR940405-1-00145 1 151
during FR940405-1-00145 1 155
15. FR940405-1-00145 1 163
describe FR940405-1-00145 1 164
specifications FR940405-1-00145 1 166
an FR940405-1-00145 1 168
light FR940405-1-00145 1 170
source FR940405-1-00145 1 171
method FR940405-1-00145 1 176
eg FR940405-1-00145 1 178
spectral FR940405-1-00145 1 180
distribution FR940405-1-00145 1 181
intensity FR940405-1-00145 1 183
etc FR940405-1-00145 1 185
agency FR940405-1-00145 3 188 257 276
has FR940405-1-00145 1 189
concluded FR940405-1-00145 1 190
under FR940405-1-00145 1 192
21 FR940405-1-00145 2 193 231
cfr FR940405-1-00145 2 194 232
10.65 FR940405-1-00145 1 195
it FR940405-1-00145 2 198 385
would FR940405-1-00145 1 199
public FR940405-1-00145 4 203 208 247 610
interest FR940405-1-00145 1 204
hold FR940405-1-00145 1 206
a FR940405-1-00145 9 207 407 442 508 541 718 724 757 882
meeting FR940405-1-00145 6 209 248 411 438 611 630
discuss FR940405-1-00145 1 211
many FR940405-1-00145 1 213
questions FR940405-1-00145 4 214 302 333 426
topics FR940405-1-00145 3 216 335 428
associated FR940405-1-00145 1 217
with FR940405-1-00145 4 218 371 469 563
otc FR940405-1-00145 2 222 594
sunscreen FR940405-1-00145 3 223 595 721
drug FR940405-1-00145 2 224 596
products FR940405-1-00145 2 225 597
proposed FR940405-1-00145 1 228
rulemaking FR940405-1-00145 3 229 289 598
involves FR940405-1-00145 1 230
parts FR940405-1-00145 1 233
352 FR940405-1-00145 2 234 254
700 FR940405-1-00145 1 236
740 FR940405-1-00145 1 239
; FR940405-1-00145 1 240
however FR940405-1-00145 2 241 273
discussion FR940405-1-00145 1 244
will FR940405-1-00145 3 249 575 616
limited FR940405-1-00145 2 251 297
part FR940405-1-00145 1 253
requests FR940405-1-00145 2 258 277
information FR940405-1-00145 4 259 283 393 487
regarding FR940405-1-00145 1 260
claims FR940405-1-00145 1 263
procedures FR940405-1-00145 2 267 341
any FR940405-1-00145 5 269 305 350 400 500
interested FR940405-1-00145 3 270 404 433
person FR940405-1-00145 3 271 504 587
only FR940405-1-00145 3 279 423 605
new FR940405-1-00145 1 280
additional FR940405-1-00145 1 282
not FR940405-1-00145 2 284 387
previously FR940405-1-00145 3 285 395 430
included FR940405-1-00145 1 286
submitted FR940405-1-00145 4 291 355 394 465
specifically FR940405-1-00145 2 296 603
asked FR940405-1-00145 1 303
individual FR940405-1-00145 2 306 401
group FR940405-1-00145 2 308 403
may FR940405-1-00145 3 309 360 557
on FR940405-1-00145 5 311 336 446 546 625
before FR940405-1-00145 2 313 448
submit FR940405-1-00145 2 316 361
dockets FR940405-1-00145 8 319 453 697 790 810 830 850 867
management FR940405-1-00145 8 320 454 698 791 811 831 851 868
branch FR940405-1-00145 8 321 455 699 792 812 832 852 869
( FR940405-1-00145 12 322 416 456 633 701 743 777 794 814 834 854 871
address FR940405-1-00145 5 323 417 424 457 491
above FR940405-1-00145 3 324 418 458
) FR940405-1-00145 12 325 419 459 635 703 745 779 796 816 836 856 873
comments FR940405-1-00145 5 327 351 366 536 624
contained FR940405-1-00145 1 342
this FR940405-1-00145 5 344 382 397 480 609
document FR940405-1-00145 3 345 383 481
two FR940405-1-00145 1 347
copies FR940405-1-00145 1 348
except FR940405-1-00145 1 357
individuals FR940405-1-00145 1 359
one FR940405-1-00145 1 362
copy FR940405-1-00145 1 363
all FR940405-1-00145 2 365 461
identified FR940405-1-00145 2 370 468
docket FR940405-1-00145 9 373 398 471 692 785 805 825 845 862
number FR940405-1-00145 4 374 472 494 552
found FR940405-1-00145 2 375 473
brackets FR940405-1-00145 2 377 475
heading FR940405-1-00145 2 380 478
necessary FR940405-1-00145 1 388
resubmit FR940405-1-00145 1 390
making FR940405-1-00145 1 406
presentation FR940405-1-00145 4 408 509 514 525
contact FR940405-1-00145 1 413
jeanne FR940405-1-00145 1 414
rippere FR940405-1-00145 1 415
presentations FR940405-1-00145 2 421 560
listed FR940405-1-00145 1 429
persons FR940405-1-00145 2 432 562
participating FR940405-1-00145 1 435
must FR940405-1-00145 1 439
also FR940405-1-00145 1 440
send FR940405-1-00145 1 441
notice FR940405-1-00145 1 443
participation FR940405-1-00145 3 445 464 572
notices FR940405-1-00145 2 462 570
contain FR940405-1-00145 1 484
following FR940405-1-00145 1 486
: FR940405-1-00145 1 488
name FR940405-1-00145 1 489
telephone FR940405-1-00145 1 493
business FR940405-1-00145 1 496
affiliation FR940405-1-00145 1 497
if FR940405-1-00145 1 499
desiring FR940405-1-00145 1 505
make FR940405-1-00145 1 507
summary FR940405-1-00145 1 511
approximate FR940405-1-00145 1 518
amount FR940405-1-00145 1 519
time FR940405-1-00145 3 521 548 583
requested FR940405-1-00145 2 522 532
groups FR940405-1-00145 1 527
having FR940405-1-00145 1 528
similar FR940405-1-00145 1 529
interests FR940405-1-00145 2 530 565
consolidate FR940405-1-00145 1 534
their FR940405-1-00145 1 535
present FR940405-1-00145 1 538
them FR940405-1-00145 1 539
through FR940405-1-00145 1 540
single FR940405-1-00145 1 542
representative FR940405-1-00145 1 543
depending FR940405-1-00145 1 545
participants FR940405-1-00145 1 554
fda FR940405-1-00145 3 556 574 642
require FR940405-1-00145 1 558
joint FR940405-1-00145 1 559
by FR940405-1-00145 1 561
common FR940405-1-00145 1 564
reviewing FR940405-1-00145 1 568
notify FR940405-1-00145 1 576
each FR940405-1-00145 2 577 586
participant FR940405-1-00145 1 578
schedule FR940405-1-00145 1 581
allotted FR940405-1-00145 1 584
administrative FR940405-1-00145 2 590 614
record FR940405-1-00145 2 591 615
being FR940405-1-00145 1 600
reopened FR940405-1-00145 1 601
include FR940405-1-00145 1 604
proceedings FR940405-1-00145 1 607
remain FR940405-1-00145 1 617
open FR940405-1-00145 1 618
until FR940405-1-00145 1 619
allow FR940405-1-00145 1 623
matters FR940405-1-00145 1 626
raised FR940405-1-00145 1 627
references FR940405-1-00145 1 632
letters FR940405-1-00145 1 636
w. FR940405-1-00145 1 638
e. FR940405-1-00145 1 639
gilbertson FR940405-1-00145 1 640
t. FR940405-1-00145 1 645
p. FR940405-1-00145 1 646
koestler FR940405-1-00145 1 647
westwood FR940405-1-00145 1 649
pharmaceuticals FR940405-1-00145 1 650
inc. FR940405-1-00145 1 652
k. FR940405-1-00145 1 654
m. FR940405-1-00145 3 655 671 877
o'brien FR940405-1-00145 1 656
scheringplough FR940405-1-00145 1 658
corp. FR940405-1-00145 1 659
n. FR940405-1-00145 2 661 706
j. FR940405-1-00145 2 662 707
lowe FR940405-1-00145 2 663 704
ucla FR940405-1-00145 1 665
school FR940405-1-00145 2 666 677
medicine FR940405-1-00145 1 668
a. FR940405-1-00145 2 672 748
pathak FR940405-1-00145 1 673
harvard FR940405-1-00145 1 675
medical FR940405-1-00145 1 676
coded FR940405-1-00145 1 679
let45 FR940405-1-00145 1 680
let47 FR940405-1-00145 1 682
let50 FR940405-1-00145 1 684
let52 FR940405-1-00145 1 687
respectively FR940405-1-00145 1 689
no FR940405-1-00145 11 693 781 786 801 806 821 826 841 846 858 863
78n0038 FR940405-1-00145 6 695 788 808 828 848 865
et FR940405-1-00145 2 708 878
al. FR940405-1-00145 2 709 879
`` FR940405-1-00145 3 711 756 881
indoor FR940405-1-00145 1 712
outdoor FR940405-1-00145 1 714
efficacy FR940405-1-00145 1 715
broad FR940405-1-00145 1 719
spectrum FR940405-1-00145 2 720 760
against FR940405-1-00145 1 722
ultraviolet FR940405-1-00145 2 723 762
psoralensensitized FR940405-1-00145 1 727
subjects FR940405-1-00145 1 728
'' FR940405-1-00145 3 730 769 895
journal FR940405-1-00145 2 731 771
american FR940405-1-00145 1 734
academy FR940405-1-00145 1 735
dermatology FR940405-1-00145 1 737
17:224230 FR940405-1-00145 1 739
1987 FR940405-1-00145 2 741 775
3 FR940405-1-00145 1 744
mckinlay FR940405-1-00145 1 746
f. FR940405-1-00145 1 749
b. FR940405-1-00145 1 752
l. FR940405-1-00145 1 753
diffey FR940405-1-00145 1 754
reference FR940405-1-00145 3 758 797 817
action FR940405-1-00145 1 759
induced FR940405-1-00145 1 763
erythema FR940405-1-00145 1 764
human FR940405-1-00145 1 766
cie FR940405-1-00145 1 770
6:1722 FR940405-1-00145 1 773
4 FR940405-1-00145 1 778
comment FR940405-1-00145 5 780 800 820 840 857
c104 FR940405-1-00145 1 783
5 FR940405-1-00145 1 795
29 FR940405-1-00145 1 798
c128 FR940405-1-00145 3 803 823 843
6 FR940405-1-00145 1 815
30 FR940405-1-00145 1 818
7 FR940405-1-00145 1 835
figure FR940405-1-00145 1 837
8 FR940405-1-00145 1 855
135 FR940405-1-00145 1 860
9 FR940405-1-00145 1 872
sayre FR940405-1-00145 1 874
r. FR940405-1-00145 1 876
comparison FR940405-1-00145 1 883
vivo FR940405-1-00145 1 886
vitro FR940405-1-00145 1 889
sunscreening FR940405-1-00145 1 892
formulas FR940405-1-00145 1 893
photochemistry FR940405-1-00145 1 896
photobiology FR940405-1-00145 1 898
29:559566 FR940405-1-00145 1 900
1979 FR940405-1-00145 1 902
( FR940405-1-00146 4 0 34 72 111
10 FR940405-1-00146 1 1
) FR940405-1-00146 4 2 36 74 113
sayre FR940405-1-00146 1 3
, FR940405-1-00146 18 4 9 20 29 31 38 41 46 56 62 67 76 79 83 97 106 108 116
r. FR940405-1-00146 2 5 43
m. FR940405-1-00146 1 6
et FR940405-1-00146 1 7
al. FR940405-1-00146 1 8
`` FR940405-1-00146 3 10 47 84
sunscreen FR940405-1-00146 2 11 90
testing FR940405-1-00146 1 12
methods FR940405-1-00146 1 13
: FR940405-1-00146 1 14
in FR940405-1-00146 2 15 48
vitro FR940405-1-00146 2 16 49
predictions FR940405-1-00146 1 17
of FR940405-1-00146 5 18 23 26 100 103
effectiveness FR940405-1-00146 1 19
'' FR940405-1-00146 3 21 57 98
journal FR940405-1-00146 2 22 99
the FR940405-1-00146 3 24 94 101
society FR940405-1-00146 2 25 102
cosmetic FR940405-1-00146 2 27 104
chemists FR940405-1-00146 2 28 105
31:133143 FR940405-1-00146 1 30
1980 FR940405-1-00146 1 32
. FR940405-1-00146 6 33 60 65 71 110 119
11 FR940405-1-00146 1 35
cole FR940405-1-00146 1 37
c. FR940405-1-00146 1 39
a. FR940405-1-00146 1 40
and FR940405-1-00146 3 42 53 80
l. FR940405-1-00146 2 44 78
vanfossen FR940405-1-00146 1 45
models FR940405-1-00146 1 50
for FR940405-1-00146 1 51
uvb FR940405-1-00146 1 52
uva FR940405-1-00146 1 54
photoprotection FR940405-1-00146 1 55
comment FR940405-1-00146 2 58 117
no FR940405-1-00146 3 59 64 118
rc1 FR940405-1-00146 1 61
docket FR940405-1-00146 1 63
78n0038 FR940405-1-00146 1 66
dockets FR940405-1-00146 1 68
management FR940405-1-00146 1 69
branch FR940405-1-00146 1 70
12 FR940405-1-00146 1 73
diffey FR940405-1-00146 1 75
b. FR940405-1-00146 1 77
j. FR940405-1-00146 1 81
robson FR940405-1-00146 1 82
a FR940405-1-00146 1 85
new FR940405-1-00146 1 86
substrate FR940405-1-00146 1 87
to FR940405-1-00146 1 88
measure FR940405-1-00146 1 89
protection FR940405-1-00146 1 91
factors FR940405-1-00146 1 92
throughout FR940405-1-00146 1 93
ultraviolet FR940405-1-00146 1 95
spectrum FR940405-1-00146 1 96
40:127188 FR940405-1-00146 1 107
1989 FR940405-1-00146 1 109
13 FR940405-1-00146 2 112 115
reference FR940405-1-00146 1 114
c257 FR940405-1-00146 1 120
